Gene therapy group Oxford Biomedica said Boehringer Ingelheim had exercised an option to license its technology to make a treatment for cystic fibrosis.
Refractory products provider RHI Magnesita warned it could miss its annual earnings guidance after cost pressures and the temporary closure of an Austrian facility weighed...
Price comparison group Moneysupermarket.com said its third-quarter revenue fell 10% as competition for insurance visitors intensified, though it stuck to earnings guidance citing resilient margins....